Active Ingredient: POSACONAZOLE
Proprietary Name: POSACONAZOLE
Dosage Form; Route of Administration: SUSPENSION; ORAL
Strength: 40MG/ML
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A208773
Product Number: 001
Approval Date: May 15, 2020
Applicant Holder Full Name: HIKMA PHARMACEUTICALS USA INC
Marketing Status:
Prescription
Patent and Exclusivity Information